EP-1834 Feasibility study of extreme hypofractionated proton treatment planning for prostate cancer. (April 2019) - Klinker, P.; Brouwer, C.; Roos, C.; Hammer, C.; Vanhauten, H.; Bijmolt, S.; Langendijk, J.; Both, S.; Van den Bergh, A.; Al-Uwini, S.